In meta-analysis of national and subnational #TB prevalence surveys, we found that between 2000-2024, tuberculosis epidemics are rapidly urbanising.
doi.org/10.1371/jour...
@plosmedicine.org
@uofgshw.bsky.social
@kchorton.bsky.social
Posts by RESIST-TB
Work in progress: sars-2 clearly increases risk of tuberculosis activation in central Ontario, on a timeline that is consistent with T cell injury. It does not impact risk of non tuberculous mycobacterial infections
More follows
🚨 BREAKING: Scientists develop an intranasal DNA vaccine targeting drug-resistant tuberculosis a potential game-changer in global TB control.
This could improve prevention and strengthen protection against one of the world’s most dangerous infectious diseases.
The Union is offering a free and accessible course created for clinicians and program managers who are working or planning to work with DR-TB. Learn more here! www.youtube.com/watch?v=J0h-...
After years without much advancement in new TB drug trials, a vaccine and two treatments are progressing through late-stage studies. This article highlights a few current trials that could have major impacts on TB globally. www.clinicaltrialsarena.com/features/tri...
Check out our latest monthly newsletter and subscribe in the top left corner! mailchi.mp/1d96f24b9449...
SAVE THE DATE: Ahead of the Data? The NC‑009 TB Trial Results and a Predictive Translational Model.
We hope you can join us for our next webinar 'Ahead of the Data? The NC‑009 TB Trial Results and a Predictive Translational Model' on April 14th at 11am ET!
Our analysis of #TB exposure and transmission patterns is now in @pnas.org. @petedodd24.bsky.social and I found a majority of TB transmission globally is attributable to contact with adult men, while contributions to transmission by age are more variable across regions.
www.pnas.org/doi/10.1073/...
Advocates in front of Massachusetts congressional offices
Advocates in front of Massachusetts congressional offices
Advocates at Union Pub in Washington DC
Advocates in front of Massachusetts congressional offices
We Are TB’s Kelly was in DC on #TBHillDay ! Thanks to offices of @repauchincloss.bsky.social @warren.senate.gov @trahan.house.gov & Rep. Lynch for meeting w/ Kelly, @stoptbusa.bsky.social and the @tbfighters.org ! ALSO: Check out Kelly on this TB ED Talk TONIGHT!! www.youtube.com/live/g4gE2bp...
RESIST-TB is excited to share that Dr. Max O'Donnell is joining our steering committee! An Associate Professor of Medicine & Epidemiology at Columbia University Irving Medical Center, Max leads a multidisciplinary research program focused on global health. Read here! www.resisttb.org/max-o-donnell1
Researchers from the University of Virginia have received a grant from the Pittsfield Anti-Tuberculosis Association to create a global, web-based resource to further support nurses that are caring for individuals with DR-TB. Read more here! mcusercontent.com/d8f4400bf69c...
A 6month oral treatment for rifampicin-resistant TB was more effective and more cost effective compared to the longer therapies/medications currently used in India. An economic evaluation found that BPaL-based regimens are more likely to be cost effective or cost saving. www.ndtv.com/health/6-mon...
Check out our latest monthly newsletter and subscribe in the top left corner! mailchi.mp/a2a84c4f7b72...
one type of foreign aid that developing countries are having trouble finding another way to fund is testing for diseases, like whether the TB responds to antibiotics, is multi-drug resistant (MDR), or extremely drug resistant (XDR); and stipends for health care workers to test/treat diseases at home
Health professionals can now use photographing film x-rays to create digital files and then give those files to AI. This new diagnostic tool can improve the detection/diagnosis of TB on chest x-rays in areas where resources and radiologists may be scarce. www.auntminnie.com/clinical-new...
Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/7259f8767b81...
A new study from Mumbai published in PLOS Global Public Health shows adults with MDR‑TB face severe nutrition deficits—far worse than household or community controls. It presents a strong case for integrating nutrition into TB care.
journals.plos.org/globalpublic...
“Cases of active tuberculosis in San Francisco increased by 35% from 2023 to 2024 — more than three times the national rate and twice the California rate…”
Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries
✅ Just Accepted
🔗 https://bit.ly/3Lyvb6u
Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/6a69e810f2f1...
A recent study has demonstrated that rifampicin when paired with a second compound called AAP-SO2, becomes a more powerful treatment in both suppressing TB resistance and targeting the dormant TB bacteria that other medications struggle to attack. Read more here! www.rockefeller.edu/news/38777-t...
TB claims 1.2 million lives each year. New vaccine candidates currently in late-stage trials may help reduce this toll, but only if countries can access them without delay.
Gavi’s CEO Dr Sania Nishtar sets out the path forward: bit.ly/4ikaLtG
A quote card with a light tie dye background. "No disease, especially tubrculosis, should be about capital. - Dr. Edward Robitzek in The Black Angels by Maris Smilios"
Wealth has a large impact on quality of care, or even if one gets care, as individuals like Dr. Robitzek saw in his personal and professional life. How does income impact a person’s experience with TB, both today and in the past? #TBReaders
Mycobacterium tuberculosis is an outlier in many ways. One of them is keeping a high degree of functional redundancy despite its obligate pathogen lifestyle. In this review, we reflect on the biological meaning of M. tuberculosis functional redundancies.
journals.plos.org/plospathogen...
Data from a phase II trial showed that sorfequiline had greater activity against drug-susceptible TB compared to existing treatments at 8 weeks in addition to a more favorable safety profile, giving hope for a new, shorter treatment option. Read more here!
www.cidrap.umn.edu/tuberculosis...
MDR-TB has been decreasing globally since 2015, with the estimated number of people who have developed MDR-TB in 2024 at 390,000. Read more about MDR-TB trends globally in the WHO Global Tuberculosis Report 2025: 1.3 Drug-Resistant TB.
www.who.int/teams/global...
Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/463e0f0397ad...
TB is making a comeback.
Malnutrition and overcrowding create ideal conditions for tuberculosis to spread. It often takes years for symptoms to appear. Meanwhile, the disease spreads. There is no vaccine in the US. See John Green’s book, Everything is Tuberculosis
everythingistb.com